右美托咪定与丙泊酚对清醒开颅术中癫痫发作的影响:一项回顾性研究
该回顾性单中心研究分析了2014年1月至2019年12月间168例清醒开颅术患者,其中58例使用右美托咪定(DEX)、110例使用丙泊酚。DEX组术中癫痫发作(IOS)发生率高于丙泊酚组(22% vs 11%,P=0.046),DEX组心动过缓发生率更高,丙泊酚组高血压发生率和平均心率更高。单因素回归中DEX有促进IOS的趋势但未达统计学显著(OR=2.36,P=0.051)。
要点
- DEX组IOS发生率为22%,高于丙泊酚组的11%(P=0.046)。
- DEX组心动过缓发生率更高(P<0.001),丙泊酚组高血压和平均心率更高(P=0.006和P<0.001)。
- 单因素回归中DEX有促进IOS的趋势但未达统计学显著(OR=2.36,P=0.051)。
核心结论
- 在清醒开颅术中,使用DEX的患者经皮质脑电图检测到的IOS发生率高于使用丙泊酚的患者。
- 但DEX组患者并未显示出统计学显著的IOS发生风险增加。
- 对于肿瘤相关癫痫患者,DEX是丙泊酚在清醒开颅术中的有效替代选择。
研究设计与样本
- 回顾性单中心研究,分析2014年1月至2019年12月期间进行的清醒开颅术。
- 共纳入168例成人患者,其中58例使用DEX,110例使用丙泊酚。
- 记录所有经皮质脑电图检测到的IOS及生命体征。
主要发现
- DEX组IOS发生率为22%,丙泊酚组为11%(P=0.046)。
- DEX组心动过缓发生率更高(P<0.001)。
- 丙泊酚组高血压发生率更高(P=0.006),平均心率更高(P<0.001)。
- 两组均未发生需要主动药物干预的严重不良事件。
- 单因素回归分析中,DEX显示促进IOS发生的趋势但无统计学显著性(OR=2.36,P=0.051)。
临床怎么用
- 对于肿瘤相关癫痫患者,DEX可作为丙泊酚在清醒开颅术中的有效替代选择(作者认为)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The effect of dexmedetomidine (DEX) compared with propofol on intraoperative seizures (IOSs) detected using electrocorticography during awake craniotomy for resection of brain tumors is unknown. This investigation aimed to compare IOS rate in patients receiving DEX versus propofol as sedative agent. METHODS: In this retrospective single-center study, awake craniotomies performed from January 2014 to December 2019 were analyzed. All IOSs detected by electrocorticography along with vital signs were recorded. RESULTS: Of 168 adults enrolled in the study, 58 were administered DEX and 110 were administered propofol. IOSs occurred more frequently in the DEX group (22%) versus the propofol group (11%) (P = 0.046). A higher incidence of bradycardia was also observed in the DEX group (P < 0.001). Higher incidence of hypertension and a higher mean heart rate were recorded in the propofol group (P = 0.006 and P < 0.001, respectively). No serious adverse events requiring active drug administration were noted in either group. At univariate regression analysis, DEX demonstrated a tendency to favor IOS onset but without statistical significance (odds ratio = 2.36, P = 0.051). Patients in both groups had a similar epilepsy outcome at the 1-year postoperative follow-up. CONCLUSIONS: IOSs detected with electrocorticography during awake craniotomy occurred more frequently in patients receiving DEX than propofol. However, patients receiving DEX were not shown to be at a statistically significant greater risk for IOS onset. DEX is a valid alternative to propofol during awake craniotomy in patients affected by tumor-related epilepsy.
引用
- Deana C, Pez S, Ius T, et al. Effect of Dexmedetomidine versus Propofol on Intraoperative Seizure Onset During Awake Craniotomy: A Retrospective Study. World Neurosurg. 2023. PMID: 36682527. doi:10.1016/j.wneu.2023.01.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。